Venus Medtech to acquire Keystone Heart

Venus Medtech signed an agreement to acquire Keystone Heart Ltd., a medical device company making the TriGUARD 3 cerebral embolic protection device. The acquisition gives Venus Medtech international rights to the device and establishes a presence in the US and EMEA.

“It is of utmost importance to us that our devices improve the quality life of the patients whom receive them.”prnewswire.com

• 1 source
• prnewswire.comVenus Medtech Announces Agreement to Acquire Keystone Heart, LTDKeystone Heart Ltd.Sep 25, 2018

Summarized from public sources; check the original articles before acting on it.